Objective: Promoting angiogenesis may be an effective treatment for patients with diffuse peripheral vascular disease. This study investigated whether estrogen can promote angiogenesis and perfusion in a rabbit model of chronic limb ischemia. Methods and results: Ischemia was induced in one hindlimb of 24 oophorectomized New Zealand White rabbits. Ten days later (day 0), they were randomized into 4 groups for intramuscular treatment in the ischemic limb: controls receiving saline at day 0; Estrogen-1 group receiving estradiol valerate, modified release (EVMR), 1 mg / kg at day 0; Estrogen-2 group receiving EVMR 1 mg / kg at days 0 and 15; and Estrogen-3 group receiving EVMR 2 mg / kg at day 0. Revascularization was evaluated by clinical indexes, such as ischemic / normal limb systolic blood pressure (BPR), and capillary density / muscle fiber in the abductor muscle of the ischemic limb at the time of death (day 30). At day 30 the BPR was increased in all groups (0.3960.08 in the controls, 0.5260.11 in the Estrogen-1 group, 0.6560.13 in the Estrogen-2 group and 0.6160.16 in the Estrogen-3 group, F 52.39, P50.04). The capillary / muscle fiber at day 30 was 0.8760.09, 1.0860.15, 1.0160.14 and 1.1060.9 (F 55.01, P50.01), respectively, in the 4 groups. The capillary / muscle fiber was related to BPR (r50.48, P,0.02) and to 17-b estradiol plasma levels of day 15 (r50.58, P50.003) and of day 30 (r50.46, P,0.02). Conclusion: Administration of estrogen promotes angiogenesis and perfusion in ischemic rabbit hindlimbs. Thus, estrogen may represent a new therapeutic modality in the management of arterial insufficiency.
1. Introduction steroid hormones, particularly 17-b estradiol [4] . Several manifestations of vascular disease, such as lupus erytheDespite the major advances in medical, surgical and matosus and Takayasu's arteritis, suggest that endothelial percutaneous revascularization techniques, limb salvage cell activity and formation of new vessels may be regand relief of ischemic pain cannot be achieved in many ulated by sex hormones. Both these diseases are associated patients with diffuse peripheral vascular disease [1] . In with endothelial cell proliferation. A role for gonadal such patients, promoting angiogenesis may be an effective steroids in modulating endothelial cell behavior is suptreatment [2] .
ported by studies of blood vessel formation in the primate Angiogenic activity is generally low in the adult organendometrium [5] . Gonadal steroids directly affect blood ism, except for the normal cyclical changes that occur in vessels by increasing the secretion of endothelium-derived the female reproductive tract [3] . It is likely that neovascurelaxing factor (nitric oxide) [6] . larization in reproductive tissues is under the control of Morales et al. [7] demonstrated in vitro and in vivo that estradiol enhances human umbilical vein endothelial cell activities (non-endometrial endothelial cells). These cells play an important role in neovascularization, suggesting a formed after ligation of the vascular pedicle. The ovarian promoting influence of estrogens on angiogenesis. It has samples excised were analyzed and confirmed histologicalalso been demonstrated recently that estrogen stimulates ly. After oophorectomy the rabbits were left for 10 days delayed mitogen-activated protein kinase activity in human for postoperative recovery and they then underwent femorendothelial cells via an autocrine loop that involves basic al artery dissection and were randomly assigned to one of fibroblast growth factor [8] . Estradiol also enhances endofour groups: thelial cell attachment, proliferation, migration, and differentiation in vitro and markedly increases the angiogenic
• Control group. The rabbits received placebo (n57).
effect of basic fibroblast growth factor in mice in vivo [7] .
• Estrogen-1 group. The rabbits received estradiol valer-
The aim of the present study was to test the hypothesis ate, modified release (EVMR) 1 mg / kg at day 0 (n56). that exogenous estrogen can promote angiogenesis and
• Estrogen-2 group. The rabbits received EVMR 1 mg / kg perfusion in a rabbit model of chronic limb ischemia. at day 0 and day 15 (n56).
• Estrogen-3 group. The rabbits received EVMR 2 mg / kg at day 0 (n55).
Methods
The purpose of this grouping was to examine possible dose 2.1. Animal model effects of estrogen therapy.
The angiogenic response to intramuscular administration 2.3. Administration of estrogen of estradiol in vascular insufficiency was investigated using a rabbit ischemic hindlimb model [9, 10] which was EVMR (Progynon Depot 10 mg) was provided by designed to simulate ischemia characteristic of patients Schering AG, Germany, and was stored in a cool and dry with lower extremity arterial occlusive disease. The Athens
place. An interval of 10 days between the time of the Animal-care Committee approved (no. 5007) all protocols.
second surgery (artery dissection) and administration of The care of the animals complied with the guidelines of estrogen or placebo was allowed for the rabbits' postoperathe European Community and of the department of Extive recovery and the development of endogenous collater- [11] . The surgical preparation we used produce persistent revised 1996).
hindlimb ischemia for at least 90 days, with decreased A total of 24 oophorectomized female New Zealand regional distribution of blood flow in rabbit calves [12] . White rabbits (weighing 3.6 to 4.2 kg, mean weight 3.9 kg, For this reason, saline or estrogen was administered aged 7-9 months) were anesthetized with Ketamine (30 intramuscularly in three sites in the ischemic limb, as in mg / kg) and occasionally sodium pentothal (25 mg / kg iv) other studies [9] , in order to have high local concenwas administered as needed. A longitudinal incision was trations. then performed in the right thigh, extending inferiorly from Ten days after the induction of limb ischemia (day 0), the inguinal ligament. Through this incision, using surgical saline or estrogen, 0.4 ml, was administered intramuscularloops, the femoral artery was dissected free along its entire ly into the ischemic limb, except for the Estrogen-3 group length, as were major branches of the femoral artery in which 0.8 ml was administered. Each injection was including the inferior epigastrial, deep femoral, lateral given intramuscularly at three different sites in the thigh of circumflex and superficial epigastric arteries. After the the ischemic limb: 50% of the injection liquid in the popliteal and saphenous arteries were further dissected medial thigh, 25% in the lateral thigh and 25% in the distal distally, the external iliac artery and all of the above thigh near the knee. All of the above-described procedures arteries were ligated. Finally, the femoral artery was were completed without the use of heparin. Revascularizacompletely excised, from its proximal origin as a branch of tion in the ischemic limb was evaluated by clinical the external iliac artery to the point distally where it assessment and calf blood pressure measurement, and in bifurcates into the saphenous and popliteal arteries.
terms of capillary density and capillary to muscle fiber Each animal received sodium chloride 0.9% (50 ml / h ratio as described below. iv) during the surgery and Cephamandol (30 mg / kg bolus iv).
Estradiol plasma level measurements

Study groups
Blood samples from each rabbit were collected in tubes containing EDTA before oophorectomy and at day 0, 15 Under anesthesia the peritoneal cavity was entered via a and 30 (the end of the experiment) for 17-b estradiol low middle incision and bilateral ovariectomy was perplasma measurements.
Estradiol plasma levels were measured by electroformation was examined by measuring the number of chemiluminescent technology (Elecsys 2010 Immunoassay capillaries in tissue sections under light microscopy. Tissue system, Hitachi, USA).
sections were obtained from the abductor striated muscle, from both the ischemic and the non-ischemic limb at the time of death (day 30). This muscle was chosen for light 2.5. Clinical assessment microscopic analysis because it is a major muscle of the medial thigh and it was originally perfused by the deep At day 0, before initiation of estrogen or normal saline femoral artery, which was ligated at the same time that the treatment, and at days 15 and 30, after initiation of femoral artery was excised. treatment, all rabbits were clinically evaluated for inci-
The tissue samples were fixed in formaline and were dence of distal limb necrosis by macroscopic examination; subsequently paraffin embedded. Sections were cut at 3 this was considered significant if skin necrosis was obmm onto silane coated slides with muscle fibers oriented in served at the foot or ankle.
a transverse fashion. The slides were stained with the streptavidin method, using anti-factor VIII as a primary antibody (DAKO, UK) for the detection of the endothelial 2.6. Calf blood pressure ratio cells. For immunohistochemistry, dewaxing was performed Calf blood pressure was measured serially in both using citroclear for 15 min before passing through graded hindlimbs using a Doppler flowmeter with an 8 MHz alcohols (100% ethanol, 100% ethanol, and 70% ethanol) transducer (Direction volume meter, DVM 1200-Hadeco, into water. The sections were then placed into a tris buffer USA) immediately before treatment (day 0) as well as on saline for 5 min before the application of antigen retrieval days 15 and 30 after initiation of the therapy. On each techniques. After dewaxing, sections were placed in a glass occasion, with the rabbits under sedation, the hindlimbs rack and put into a 0.1 M sodium citrate buffer. The were shaved and cleaned, the pulse of the posterior tibial solution with slides was heated by microwave (ProLine artery was identified using a Doppler probe and the Powerwave 800) for 234 min at 750 watts and left to cool systolic blood pressure in both limbs was determined using for 25 min. The slides were washed three times in tris standard techniques. The calf blood pressure ratio (BPR) buffer saline before application of the primary antibody. was defined for each rabbit as the ratio of the systolic After application of the primary antibody, a biotinylated pressure of the ischemic limb to that of the normal limb.
goat antimouse antibody (DAKO, UK) at 1:40 was overBy combining coronary wedge pressure (P ) with W laid. The tertiary antibody complex of streptavidin-biotinsimultaneously recorded aortic pressure (P ) and central a horse radish peroxidase (DAKO, UK) was then applied, venous pressure (P ) at maximum arterial vasodilation, a v diaminobenzidine was used as a chromogen and counterquantitative index of collateral flow can be calculated, at stained with hematoxylin. Blocking of endogenous perleast during artery occlusion by balloon inflation [13] . This oxidase in paraffin-embedded tissues was performed by index, called fractional collateral blood flow, expresses incubation of the section for 20 min in 0.5% H O in actual collateral flow (Q ) as a ratio to normal maximum three washing steps of 5 min in tris buffer saline. The collateral circulation can be estimated according to Ten different fields from one muscle section were the formula [13] : randomly selected and the number of capillaries was N counted using a 203 objective to determine the capillary
density (mean number of capillaries per square millimeter) where P is the pressure in the occluded artery, P is the (Fig. 1) . The same procedure was followed in two w v right atrial pressure and P is the mean aortic pressure. additional muscle sections from different paraffin blocks of a As P is low, the formula may be changed to: the same limb. Capillaries present in five square millimev ters were counted in each limb (the range was approxi-N Q /Q 5 P /P c w a mately 800-1000 capillaries / limb). Arterioles were not included in the study. Most of them were located at the This formula has been validated in animals and in humans periphery of the muscle bundle and their number was not [14, 15] . The ischemic / normal limb arterial pressure has adequate. To ensure that the capillary density was not been used as an index for the estimation of ischemic limb overestimated because of muscle atrophy, or underestiperfusion [16] . The lower the ratio, the more the arterial mated because of interstitial edema, capillaries identified at perfusion of the ischemic limb is impaired.
necropsy were evaluated as a fraction of the muscle fibers in the histological section. The counting scheme used to 2.7. Capillary density and capillary to muscle fiber ratio compute the ratio of capillary to muscle fiber was otherwise identical to that used to compute capillary density. The effect of estradiol on collateral microvascular
The observer was blinded to treatment in performing the measurements / analyses in order to avoid potential ob-3. Results server bias.
Estrogen plasma levels
Statistical Analysis
The 17-b estradiol plasma levels were similar in all groups before oophorectomy and at day 0 (Table 1) . In all The values were analyzed using the 'Statistica' software groups 17-b estradiol plasma levels decreased, although program, (version 5, StatSoft Inc). All data were expressed not statistically significantly, after oophorectomy and in as mean value 6 standard deviation. Analysis of variance the controls they did not change significantly by days 15 with repeated measures was used for the statistical analyand 30. At day 15 these levels had increased by 130% sis, followed by Tukey's honestly significant difference (P,0.05 vs. day 0) in the Estrogen-1 group, by 90% test for post-hoc comparisons. Linear regression analysis (P5ns) in the Estrogen-2 group and by 242% (P,0.05 vs. using the least square difference was used in order to day 0) in the Estrogen-3 group. At day 30 in the Estrogenexamine possible correlations between the different vari-1 group 17-b estradiol plasma levels had decreased to ables studied. A P value of ,0.05 was considered as levels similar to those of day 0, in the Estrogen-3 group statistically significant. they remained at the same levels as day 15, whereas in the Estrogen-2 group they had increased by a further 37% 17-b estradiol plasma levels of the same day (r50.43, (P,0.05 vs. day 0). The 17-b estradiol levels of day 30 in P50.03). the Estrogen-2 and Estrogen-3 groups were higher than in At day 0, immediately before initiation of the therapy, the controls and the Estrogen-1 group on the same day.
ischemic / normal limb blood pressure demonstrated severe ischemia and was similar in all four groups (Table 2) . By 3.2. Clinical assessment day 30 the calf BPR increased statistically significantly (P,0.05) in all three treated groups of animals: in the Two rabbits from the controls, two from the Estrogen-1 Estrogen-1 group by 100%, in the Estrogen-2 group by and one from the Estrogen-3 group developed distal limb 110% and in the Estrogen-3 group by 103%. necrosis of the ischemic limb.
The systolic blood pressure of the ischemic / normal limb at day 30 was related to the capillary / muscle fiber of the 3.3. Calf blood pressure ischemic limb (r50.48, P50.02) and to the 17-b estradiol plasma levels of day 30 (r50.59, P50.002). The systolic blood pressure of the normal hind limb showed a tendency to increase in the Estrogen-1 and Estrogen-2 groups (Table 2) .
3.4. Capillary density and capillary to muscle fiber ratio The systolic blood pressure of the ischemic hind limb at day 0, immediately before initiation of the therapy, was
The capillary density was higher in the Estrogen-1, low and similar in all groups (Table 2) . By day 30 the Estrogen-2 and Estrogen-3 groups than in the controls, but blood pressure increased statistically significantly (P, this difference was of marginal significance (F 52.54, 0.05) in all three treated groups of animals: in the P50.08) ( Table 3 ). The muscle fiber density was higher in Estrogen-1 group by 96%, in the Estrogen-2 group by the controls than in the treated animals, but this difference 107% and in the Estrogen-3 group by 84%. The blood did not reach statistical significance. The capillary / muscle pressure of the ischemic limb at day 30 was related to the fiber ratio was higher in the treated animals (F 55.01, Table 3 The effects of estrogen on capillary and muscle fiber density in the ischemic hindlimb P50.01), even though in the Estrogen-2 group the differObservational studies suggest that estrogen replacement ence did not reach statistical significance. therapy in postmenopausal women reduces cardiovascular The capillary / muscle fiber density of the ischemic limb events, and this cannot be fully explained by estrogen's was related to the 17-b estradiol plasma levels of day 15 favorable effects on plasma lipoproteins [19] . To the best (r50.58, P50.003) and to those of day 30 (r50.46, of our knowledge, the current study is the first to demon-P50.02) (Fig. 2) . strate in vivo that estrogen administration can produce rapid improvement in angiogenesis and limb perfusion. Our in vivo results are in agreement with those of in vitro 4. Discussion experiments [7, 8] .
The BPR, which is a good index of collateral circulation Our results indicate that intramuscular administration of [15] , has been used in the same model for the estimation of estrogen promotes angiogenesis and perfusion in a rabbit ischemic hindlimb perfusion by other investigators [16] . model of chronic limb ischemia.
Anatomic evidence of neovascularity was investigated by The therapeutic potential of administering various annecropsy examination and documented an increase in giogenic growth factors to augment revascularization of vascularity at the capillary level, consistent with the classic the ischemic limb, as well as the myocardium, has been definition of angiogenesis formulated by Klagsbrun and demonstrated in animals [9, 11, 17] and in humans [2, 18] .
Folkman [20] . We know that in the rabbit hindlimb Estradiol enhances, in vitro and in vivo, endothelial cell collateral arteries increase their lumen 20-fold after exactivities important in neovascularization, suggesting a perimentally induced femoral artery ligation. The restorapromoting influence of estrogens on angiogenesis [7] .
tion of blood flow cannot be achieved only by an increased number of capillaries, the result of stimulated angiogen-15. Physiological levels of 17-b estradiol acutely and esis, but rather through structural enlargement by growth selectively potentiate endothelium-dependent vasodilation of preexisting arteriolar connections into true collateral in both large coronary conductance arteries and coronary arteries, that is, arteriogenesis [21] . In our study we did not microvascular resistance arteries in postmenopausal examine arteriogenesis by angiography. This is a limitation women [24] . In a previous study we showed that acute of our study, and because of that we could not distinguish intracoronary estradiol administration decreases coronary precisely if the limb perfusion augmentation was the result blood flow velocity during angioplasty in patients with of arteriogenesis per se, the direct effect of estrogens on stable angina [25] , possibly by promoting collateral artery the vasculature or a combination of the two. However, in vasodilation. This could explain our finding that the the Estrogen-1 group of animals in which the 17-b
Estrogen-2 and Estrogen-3 groups had higher, though not estradiol blood levels at day 30 had returned to the statistically significantly so, BPR measurements than the baseline (Day 0) levels, their BPR was elevated: an Estrogen-1 group, while having the same degree of indication that the increased perfusion was possibly the neovascularization; it seems, therefore, that estrogen adresult of increased neovascularization and not a direct ministration may not only promote angiogenesis but might effect of estrogens on the vasculature. Also, the finding also directly increase ischemic limb perfusion. The finding that BPR and the other clinical assessment indexes of Day that capillary / muscle fiber density was correlated to the 30 were related to the capillary / muscle fiber ratio is an 17-b estradiol means that there is a dose-dependent indication that the limb perfusion and other possible relation between estradiol blood levels and neovascularizabeneficial effects of estrogen were related to the degree of tion, even though no greater neovascularization occurred in neovascularization.
the Estrogen 2 and Estrogen-3 groups compared to the The finding of lower muscle fiber density in the hindEstrogen-1 group. Mechanisms for the increase in collaterlimbs of the animals treated with estrogen, even though not al growth with estrogen were not examined. This is a statistically significant, is possibly the result of local limitation of the study and a field for future research. edema developed via the estrogen receptor activation [22] .
In conclusion, this study demonstrates evidence of In the treated groups estradiol levels after treatment increased angiogenesis and limb perfusion after inwere higher than the pre-oophorectomy, pre-treatment tramuscular estradiol administration in rabbit ischemic levels and we therefore consider them to be satisfactory. It hindlimbs. The study thus supports the hypothesis that is, however, possible that local levels are higher than the angiogenic stimulation may represent a new therapeutic serum ones and this may be associated with the effects we modality in the management of arterial insufficiency. observed. The capillary / muscle fiber density was related to Further investigation should clarify the extent to which the the 17-b estradiol plasma levels of day 15 and of day 30.
use of estrogen may be appropriate for treatment of Systemic administration of basic fibroblast growth factor patients with lower-extremity arterial occlusive disease. enhances collateral conductance in dogs with progressive single-vessel coronary occlusion [17] . The beneficial effect of this substance occurs primarily between the 10th and
